Found 37 matching trials
Multicentre Study to Determine the Cardiotoxicity of R-CHOP Compared to R-COMP in Patients With Diffuse Large B-Cell Lymphoma
PHASE2Diffuse large B-cell lymphoma is the most prevalent subgroup within maligna...
Location
Landeskrankenhaus Feldkirch
Liposomal Doxorubicin and Docetaxel in HER2 Negative Metastatic Breast Cancer
PHASE2This is an open phase II multicentre study evaluating the efficacy and safe...
Location
Jeroen Bosch Ziekenhuis
Open Label, Single Arm, Phase II Study Using R-COMP in Elderly Patients With Aggressive NHL.
PHASE2To evaluate the safety and efficacy of R-COMP in elderly patients with adva...
Location
Multiple Locations
Taxotere®, Followed by Myocet® and Cyclophosphamide First Line Treatment in HER2 Neg Breast Cancer
PHASE2The purpose of this study is to determine how many pathological complete re...
Location
Hospital de Hospitalet
A Study of Brentuximab Vedotin, Rituximab, and Dose Attenuated CHP in Elderly Patients With Diffuse Large B-Cell Lymphoma (DLBCL)
PHASE2This is a study incorporating brentuximab vedotin and dose attenuated ritux...
Status
Active Not Recruiting
Location
James P. Wilmot Cancer Institute, University of Rochester Medical Center
Doxorubicin and Cyclophosphamide in Treating Older Women With Stage I, Stage II, or Stage III Breast Cancer That Has Been Removed By Surgery
PHASE2RATIONALE: Drugs used in chemotherapy, such as doxorubicin and cyclophospha...
Location
Centre Paul Papin
Myocet® in Children With Relapsed or Refractory Non-brainstem Malignant Glioma
PHASE1The purpose of this study is to determine the toxicity and tolerance of Myo...
Location
Centre Oscar Lambret
8 Continuous vs 8 Intermittent Cycles in First and Second Line in HER2/Neu Neg Metastatic Breast Cancer
PHASE3An open randomized phase III study to compare 8 continuous cycles of chemot...
Location
BOOG Study Center
A Study of Herceptin (Trastuzumab) in Combination Chemotherapy in Patients With Metastatic or Locally Advanced Breast Cancer
PHASE1This study will define an optimal chemotherapy dose regimen of Myocet in co...
Location
Multiple Locations
Myocet, Docetaxel & Trastuzumab as 1st Line Treatment of Patients With HER-2/Neu Positive Metastatic Breast Cancer
PHASE2To study the pharmacokinetic profile of the therapeutic schedule in order t...
Location
Ospedale Pietrantoni